At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Lotion +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Human Comedogenicity Test
In Brief
A clinical study evaluating Lotion and Negative Control for Comedogenicity. Completed, enrolled 24 participants across 1 site.
Detailed Summary
Testing comedogenicity potential of a device cream on humans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsComedogenicity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartNov 2017
Primary CompletionFeb 2018
First PostedFeb 2018
TodayJul 2026
First PostedFeb 12, 2018
Enrollment StartNov 20, 2017
Primary CompletionFeb 5, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.4 years ago
Interventions
Lotiondevice
Formulated Lotion F# 13451-131 was applied on an occlusive patch and placed on a test site on each subjects back three times a week for four weeks.
Negative Controlother
Control. An undosed occlusive patch was placed on a test site on each subjects back three times a week for four weeks.